End-stage kidney disease and kidney transplantation in HIV-positive patients in the UK Collaborative HIV Cohort (CHIC) study

Sophie José(NHS England), Caroline Sabin(Primary Health Care), John Booth(Great Ormond Street Hospital), Emil Kumar(Queen Mary University of London), Deborah I. Williams, Esther Gathogo(University of London), Stephen P. McAdoo(Imperial College Healthcare NHS Trust), Clifford Leen, Frank A. Post(King's College Hospital NHS Foundation Trust), Michael Rayment(Chelsea and Westminster Hospital NHS Foundation Trust)
UCL Discovery (University College London)
April 1, 2014
Cited by 0

Related Papers

Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
Targeting C-reactive protein for the treatment of cardiovascular disease
|Nature|2006|676
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
|The Journal of Infectious Diseases|2009|649
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
|AIDS|2014|597